Basic Information
Basic information for LINC00662-229-26aa
Peptide Name LINC00662-229-26aa
Genome Position chr19:27793551-27793628[-]
Species Human
Peptide Sequence MAGRSAPRCLPPGIRTALQSCFVLRL
Peptide Length 26
Unique No (LINC00662-206-26aa,LINC00662-211-26aa,LINC00662-212-26aa-2,LINC00662-214-26aa,LINC00662-215-26aa-1,LINC00662-216-26aa-1,LINC00662-217-26aa,LINC00662-218-26aa,LINC00662-220-26aa,LINC00662-225-26aa,LINC00662-226-26aa,LINC00662-227-26aa,LINC00662-228-26aa,LINC00662-232-26aa,LINC00662-234-26aa,LINC00662-236-26aa,LINC00662-237-26aa,LINC00662-238-26aa,LINC00662-239-26aa,LINC00662-248-26aa,LINC00662-250-26aa,LINC00662-254-26aa,LINC00662-255-26aa,LINC00662-256-26aa,LINC00662-257-26aa-1,LINC00662-262-26aa-2,LINC00662-266-26aa,LINC00662-267-26aa-1,LINC00662-270-26aa-1,LINC00662-271-26aa,LINC00662-272-26aa,LINC00662-274-26aa,LINC00662-275-26aa,LINC00662-276-26aa)
Grand Average of Hydropathicity 0.3692
Relative Molecular Mass 3264.81
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000261824;LINC00662
Transcript ID/Name ENST00000656728;LINC00662-229
Transcript Length 1348
Coding Ability 0.2871
DNA Sequence Corresponding to Peptide ATGGCCGGCAGGAGCGCACCGCGCTGTCTCCCTCCAGGGATCCGCACCGCCCTACAATCCTGCTTTGTGCTGAGATTG
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :